Cannabis Concept(BK7502),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

BK7502 Cannabis Concept

Market Closed 01-23 16:00:00 AEDT

136.60

+0.83

+0.61%

High138.34	Low135.16	Vol10.24M
Open137.54	D1 Closing135.76	Amplitude2.34%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O337.52K	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK7502","market":"AU","secType":"PLATE","nameCN":"Cannabis Concept","latestPrice":136.59811,"timestamp":1769144399960,"preClose":135.7639,"halted":0,"volume":10238115,"delay":0,"changeRate":0.006145,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":0.834213,"latestTime":"01-23 16:00:00 AEDT","open":137.54178,"high":138.33727,"low":135.15869,"amount":337520,"amplitude":0.023413,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1769468400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1769122800000,1769144400000]],"turnoverRate":0.001153,"increases":4,"decrements":2,"flats":13,"marketCap":910344677.25,"floatMarketCap":506423201.375},"requestUrl":"/m/hq/s/BK7502/wiki","defaultTab":"wiki","newsList":[{"id":"2605594394","title":"Botanix Pharmaceuticals Hosts Quarterly Update Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2605594394","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605594394?lang=en_us&edition=fundamental","pubTime":"2026-01-22 12:12","pubTimestamp":1769055174,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals Ltd. will host a Quarterly Update Webinar on Tuesday, 27 January. The event will feature the executive team presenting the Company's Quarterly Activity Report and 4C Quarterly Cash Flow Report. Pre-registration is required for participants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Botanix Pharmaceuticals Ltd. published the original content used to generate this news brief on January 22, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL4rPjrH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","BK7502","BOT.AU"],"gpt_icon":0},{"id":"2604290142","title":"Even With A 33% Surge, Cautious Investors Are Not Rewarding Elixinol Wellness Limited's (ASX:EXL) Performance Completely","url":"https://stock-news.laohu8.com/highlight/detail?id=2604290142","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604290142?lang=en_us&edition=fundamental","pubTime":"2026-01-19 06:03","pubTimestamp":1768773786,"startTime":"0","endTime":"0","summary":"Elixinol Wellness Limited ( ASX:EXL ) shareholders are no doubt pleased to see that the share price has bounced 33% in...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice1-main-header/1585186890345","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice1-main-header/1585186890345"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/household/asx-exl/elixinol-wellness-shares/news/even-with-a-33-surge-cautious-investors-are-not-rewarding-el","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/household/asx-exl/elixinol-wellness-shares/news/even-with-a-33-surge-cautious-investors-are-not-rewarding-el","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7502","BK4211","EXL.AU","BK7111","ISBC"],"gpt_icon":0},{"id":"2604235918","title":"Canaan (CAN) Valuation Checked After Hashrate Growth Buybacks And Canadian Heat Reuse Pilot","url":"https://stock-news.laohu8.com/highlight/detail?id=2604235918","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604235918?lang=en_us&edition=fundamental","pubTime":"2026-01-17 00:34","pubTimestamp":1768581299,"startTime":"0","endTime":"0","summary":"Canaan (CAN) is back in the spotlight after reporting unaudited operating results that include higher deployed hashrate, record bitcoin and ethereum holdings, and a renewed US$30 million share repurchase program.\nSee our latest analysis for Canaan.\nDespite the recent operational updates and the new Canadian heat reuse pilot, momentum in the stock has been mixed, with a 3.29% 30 day share price return, a 48.74% 90 day share price decline, and a 56.84% 1 year total shareholder return...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9621091-choice1-main-header/1585186722323","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621091-choice1-main-header/1585186722323"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-can/canaan/news/canaan-can-valuation-checked-after-hashrate-growth-buybacks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-can/canaan/news/canaan-can-valuation-checked-after-hashrate-growth-buybacks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","BK7096","BK4600","CAN","BK7502","BK4170","BK4595","BK4526"],"gpt_icon":1},{"id":"2603799426","title":"Canaan Receives Non-Compliance Notice From Nasdaq Over Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2603799426","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603799426?lang=en_us&edition=fundamental","pubTime":"2026-01-16 22:45","pubTimestamp":1768574718,"startTime":"0","endTime":"0","summary":"Canaan (CAN) said Friday that it received a notice from Nasdaq (NDAQ) over its non-compliance with Nasdaq's minimum bid price requirement.The company said it has 180 days, through July 13, to regain compliance with the listing rule and that it plans to take \"all reasonable measures\" to comply.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4170","BK7096","BK4585","BK4588","LU2095319765.USD","BK4600","LU2210149790.SGD","IE00BKPKM429.USD","LU2210150020.SGD","BK7502","SG9999014005.SGD","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014021.USD","SG9999014013.SGD","BK4526","BK4595","CAN","SG9999014039.USD","BK7508","IE00B64PRP62.GBP","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2603952233","title":"BRIEF-Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPV","url":"https://stock-news.laohu8.com/highlight/detail?id=2603952233","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603952233?lang=en_us&edition=fundamental","pubTime":"2026-01-16 14:22","pubTimestamp":1768544551,"startTime":"0","endTime":"0","summary":"BRIEF-Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPVJan 16 (Reuters) - Zelira Therapeutics Ltd ZLD.AX:US$33M FUNDRAISING INTO ZELIRAS HOPE 1 SPVFurther company coverage: ZLD.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nFWN3YG0X1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","BK7502","ZLD.AU"],"gpt_icon":0},{"id":"2603934514","title":"BUZZ-Australia's Zelira Therapeutics surges on $33 million funding for drug trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2603934514","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603934514?lang=en_us&edition=fundamental","pubTime":"2026-01-16 07:44","pubTimestamp":1768520683,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Zelira Therapeutics surges on $33 million funding for drug trial** Shares of Zelira Therapeutics ZLD.AX rise as much as 151.4% to A$0.905, hitting their highest level since Nov. 15, 2024** Stock marks its biggest intraday pct gain since May 31, 2023** Biopharma co inks deal with TGC Biotechnology fund to raise $33 million** Says funding for its HOPE1 SPV, financial structure created by co to fund development & clinical trials for its cannabinoid drug HOPE 1 ** Stock has gained 125% so far this week, up nearly 100% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nL4N3YG26B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","ZLD.AU","BK7502","BK7096"],"gpt_icon":0},{"id":"2603931608","title":"Zelira Therapeutics Ltd - US$33M Fundraising Into Zeliras Hope 1 Spv","url":"https://stock-news.laohu8.com/highlight/detail?id=2603931608","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603931608?lang=en_us&edition=fundamental","pubTime":"2026-01-16 07:04","pubTimestamp":1768518265,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YG0X1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7502","ZLD.AU","BK7096"],"gpt_icon":0},{"id":"2603524309","title":"ASX Runners of the Week: Zelira, Linq, Dalaroo and Osteopore","url":"https://stock-news.laohu8.com/highlight/detail?id=2603524309","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603524309?lang=en_us&edition=fundamental","pubTime":"2026-01-16 06:03","pubTimestamp":1768514625,"startTime":"0","endTime":"0","summary":"The Bulls N’ Bears ASX Runner of the Week is…biopharmaceutical minnow Zelira Therapeutics, which landed a transformational US$33 million funding deal to fast-track its HOPE 1 autism drug towards FDA approval.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-21327292/51ec86d5d002287b0d7df09af68cdfe012d030cc.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-21327292/51ec86d5d002287b0d7df09af68cdfe012d030cc.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-zelira-linq-dalaroo-and-osteopore-c-21327292","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-zelira-linq-dalaroo-and-osteopore-c-21327292","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["DAL.AU","LNQ.AU","BK7096","ZLD.AU","OSX.AU","BK7126","BK7095","UGL","BK7508","BK7502"],"gpt_icon":1},{"id":"2603265700","title":"BUZZ-Australia's Little Green Pharma surges on buyout offer for medical cannabis maker","url":"https://stock-news.laohu8.com/highlight/detail?id=2603265700","media":"Reuters","labels":["shareholding","corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603265700?lang=en_us&edition=fundamental","pubTime":"2026-01-14 10:18","pubTimestamp":1768357127,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Little Green Pharma surges on buyout offer for medical cannabis maker** Shares of Little Green Pharma LGP.AX rise as much as 16.7% to A$0.14, their highest level since December 23** Medical cannabis company heading for best day since December 17, if gains hold** Co to acquire Australian medicinal cannabis products manufacturer and distributor Cannatrek** Under deal, each Cannatrek shareholder will get 1.835806 new LGP shares and 0.727502 new contingent value shares for every Cannatrek share **  Existing LGP shareholders will hold ~39.5% and Cannatrek shareholders will hold~60.5% of in LGP at completion of merger** About 1.1 mln shares change hand, 4.7x their 30-day average, in their busiest day since December 15** Stock largely unchanged in 2025; up 8% so far this year  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nL6N3YF04V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGP.AU","BK7096","BK7502"],"gpt_icon":0},{"id":"2603654291","title":"BRIEF-Ecs Botanics Says Quarterly Revenue Broadly Flat QoQ At A$5.65 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2603654291","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603654291?lang=en_us&edition=fundamental","pubTime":"2026-01-14 09:14","pubTimestamp":1768353292,"startTime":"0","endTime":"0","summary":"BRIEF-Ecs Botanics Says Quarterly Revenue Broadly Flat QoQ At A$5.65 MillionJan 14 (Reuters) - ECS Botanics Holdings Ltd ECS.AX:QUARTERLY REVENUE BROADLY FLAT QUARTER-ON-QUARTER AT A$5.65 MILLIONFurther company coverage: ECS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YE16T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","ECS.AU","BK7502"],"gpt_icon":0},{"id":"2603757655","title":"Little Green Pharma Ltd-Transformational Merger of Lgp and Cannatrek","url":"https://stock-news.laohu8.com/highlight/detail?id=2603757655","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603757655?lang=en_us&edition=fundamental","pubTime":"2026-01-14 06:55","pubTimestamp":1768344952,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nTUE11XNDB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGP.AU","BK7502","BK7096"],"gpt_icon":0},{"id":"2603587946","title":"ECS Botanics - Quarterly Revenue Broadly Flat Quarter-on-Quarter at a$5.65 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2603587946","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603587946?lang=en_us&edition=fundamental","pubTime":"2026-01-14 05:38","pubTimestamp":1768340293,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nFWN3YE16T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ECS.AU","BK7096","BK7502"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0054},{"period":"3month","weight":0.0223},{"period":"6month","weight":0.0784},{"period":"1year","weight":0.2349},{"period":"ytd","weight":0.0021}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"name":"BK7502","nameEN":"BK7502"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cannabis Concept(BK7502),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cannabis Concept(BK7502) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cannabis Concept,BK7502,Cannabis Concept股票,Cannabis Concept股票老虎,Cannabis Concept股票老虎国际,Cannabis Concept行情,Cannabis Concept股票行情,Cannabis Concept股价,Cannabis Concept股市,Cannabis Concept股票价格,Cannabis Concept股票交易,Cannabis Concept股票购买,Cannabis Concept股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cannabis Concept(BK7502),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cannabis Concept(BK7502) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction